Honeywell launches a new formulation of BMI activator, which is
used to synthesise DNA and RNA oligonucleotides for therapeutic and
medical diagnostic applications. The formulation aims to result in
higher yields and lower overall...
Scientists exploring inflammation in rheumatoid arthritis have made
an unexpected discovery that may lead to new drug treatments to
ease the pain and discomfort endured by 66 million (nearly 1 in 3
adults) US citizens in 2005.
A collaboration between Anachem and chemists within the
pharmaceutical industry has resulted in the launch of the new
ReactArray Solo, which is designed to provide faster, more
efficient polymorph screening to aid drug patent protection...
Singapore's commitment to pharmaceutical research and development
goes from strength to strength after its government granted S$7.5bn
(€3.9bn) to sustain the innovation-driven growth the country has
experienced as Asia's...
Sigma-Aldrich has strengthened its position in the RNAi and
cell-based assay market by signing a series of agreements in which
the life science company has acquired a minority equity stake in
Genospectra and is granted access to various...
Oral drug development company, Phoqus, has announced that it has
completed Phase I of its clinical study on Chronocort, the first
circadian endocrine treatment for adrenal insufficiency that
current steroid therapies for this condition...
Waters Corporation has introduced new capabilities for proteomic
research by enhancing its bioanalysis software, which will allow
researchers to identify and quantify proteins and biomarkers more
efficiently.
Biotechnology company, Amgen, and Biovitrum have expanded its
existing license agreement for its treatment of metabolic
disorders, focusing on type 2 diabetes, which currently afflicts
over 160 million people worldwide.
Arpida has announced it has successfully completed a Phase I
clinical trial with oral iclaprim in a capsule formulation. This
broad-spectrum antibiotic targets infections requiring hospital
treatment, including those caused by methicillin-resistant...
NovaScreen BioSciences introduces a new side effect panel, which
aims to improve procedures in identifying potential risk factors of
drug candidates, by incorporating a broader range of receptor
subtype assays, which target a broader...
Scientists have re-engineered a well-known antibiotic to counter
drug resistance forming a new molecule in the process that could
assist in treating hospital infections, which were previously
resistant to common antibiotics putting...
GlaxoSmithKline (GSK) publishes its fourth quarter earnings, which
indicate a significant profit rise well ahead of industry
predictions, with momentum building in its product pipeline of new
drugs giving the company the go-ahead...
Supelco, a division of Sigma-Aldrich, introduces its HPLC Column,
which offers improved retention power and resolution for
difficult-to-separate analytes. The column becomes the latest in
the Ascentis' family range, adding to...
Affymetrix and Iconix have formed a collaboration to develop new
solutions for assessing the toxicological and pharmacological
properties of drugs and drug candidates.
Molecular Devices has launched its proprietary system, which offers
Fluorescence Polarisation (FP) and Time Resolved Fluorescence
Resonance Energy Transfer (TR-FRET) detection, allowing researchers
to select between these two well-known...
A UK university has joined forces with a major pharmaceutical
company in a unique collaboration, worth £2.5 million (€3.6
million) ensuring drug researchers of the future will be trained in
'magic bullet' drug R&D, which...
Evotec has announced the successful completion of the single
ascending dose component of its phase I trial for its
subtype-specific NMDA receptor antagonist drug candidate for the
treatment of Alzheimer's disease.
ARTEL announces a new laboratory innovation to improve the
performance of automated liquid handlers, introducing a system
capable of verifying multichannel instrumentation using non-aqueous
test solutions, such as Dimethyl Sulfoxide...
Animal extremist activity in the UK may be on the wane after 2005
saw incidents of damage to company, personal and public property,
halve compared to 2004. The figures indicate the effectiveness of
the Serious Organised Crime Act,...
According to a new report, automation technologies and integrated
systems are set to fuel growth in the clinical laboratory analyser
markets, accelerating the movement towards increased workstation
consolidation and more streamlined...
Amgen are to create a European Development Centre significantly
boosting UK drug R&D. The announcement echoes the UK
Government's commitment to attract more R&D investment with a
view to making the UK a leader in biotechnology.
GE Healthcare has launched a new line of uncharged IMAC media
suitable for both research and process scale-up applications, which
combines high flow rate and high binding capacity, which give
researchers the power to select the metal...
Surmodics has announced that as a result of a collaboration with
the Donaldson Company, the first of a collection of new synthetic
nanofibrillar cell culture surfaces have been produced that will
improve cell culture, cell-based bioassays...
Ingenuity Systems have launched the Ingenuity Pathways Analysis
(IPA) 3.1, a web-based software application that enables biologists
and bioinformaticians to understand biological mechanisms, pathways
and functions.
Pharmion and MethylGene has announced the formation of an
international licensing agreement potentially worth $272 million
(€224 million) for new class of compounds that inhibits gene
expression providing a tumour and haematological...
As proof of microdosing's potential in drug development,
bioanalytical CRO, Xceleron, is to lead the European Union
Microdose AMS Partnership Programme (EUMAPP) having additionally
been awarded €2.1 million to further develop...
French pharmaceutical company, Sanofi-Aventis, reported an increase
in sales for the fourth quarter with its vaccine business
continuing to impress. The company's performance precedes two
upcoming decisions later this year that...
Researchers have come up with definitive proof that proteins can be
custom-designed for a new and pre-determined activity, signalling a
new direction in drug production as well as having relevance to the
biotechnological and medicinal...
Scienion introduces its ultra low-level liquid handling system,
which allows the aspiration and dispensing of single cells or low
amount of cells for cell-based assays in the drug development
field.
Swiss pharma giants, Roche, has announced a collaboration with
Amira Pharmaceuticals, which is to focus on inflammatory disease
targets, in a deal that could build on Roche's strong position in
the inflammatory market, having...
Scientists have taken a major step forward in the diagnosis and
treatment of HIV as it was revealed that the virus' 3D structure
had been constructed. This achievement will prove instrumental in
the development of more effective...
Biovitrum and Syntonix have entered into agreement to jointly
develop and commercialise a genetically engineered product to treat
haemophilia, a rare hereditary disorder, which the life expectancy
of haemophilia patients is about...
According to a new report, technical advances in the R&D
environment have promoted the uptake of biochips in clinical
research applications. However, the report identified the high
prices as a prime area of concern.
Thermo have introduced, what it claims is the next generation of
high content screening (HCS), launching a compact system that has a
small footprint, which frees up valuable lab floor space. The
product additionally offers turnkey...
ImmuPharma, a drug discovery and development company, are to seek
admission to the Alternative Investments Market (AIM), in a move
that will give the group the resources necessary to finance initial
clinical trials on ImmuPharma's...
Genomics company, VASTox, has announced encouraging preclinical
results in its drug discovery programme, which aims to find the
next generation of treatment for Duchenne Muscular Dystrophy (DMD),
a disease of which there is no known...
Pharmaceutical company, Phosphagenics, has announced the
commencement of animal studies on its anti-cancer compound, which
claims to destroy diseased cells while not affecting normal ones by
primarily acting as a signalling molecule...
Oxford Immunotec makes available an in vitro diagnostic that
measures T-cells specific to Mycobacterium tuberculosis (MTB)
antigens diagnosing both latent and active TB infection in
immunocompromised humans - a significant problem...
Beckman Coulter makes available a new workstation that automates
microarray sample preparation for gene expression studies that
offered at a lower cost than other options on the market. The
workstation is an evolution of the higher...
Scientists have found an unusual lung-cancer tumour-suppressor
gene, which was shown to restore the inactivated gene slowing the
growth of tumour cells. Its importance in cancers of the lung and
head and neck may make it a viable...
Varian introduces two new micro extraction solid phase extraction
(SPE) formats for bioanalytical research that aims to deliver
improved performance and a more streamlined sample preparation
process enabling vacuum-free SPE processing...
MerLion Pharmaceuticals has formed a collaboration with Novartis
Institute for Tropical Diseases, which is to focus on identifying
compounds for the treatment of dengue fever, a mosquito-borne viral
infection that is prevalent in...
Enanta Pharmaceuticals has announced the initiation of Phase 2
studies investigating a first in class antibiotic candidate that
treats community-acquired respiratory tract infections, which has
become the sixth most common cause of...
Lonza has boosted its capacity to produce peptides through liquid
phase technology with the €120 million acquisition of UCB's
Bioproducts manufacturing division.
Boehringer Ingelheim has extended its joint drug discovery
collaboration with Evotec initiated in September 2004, which
targeted therapeutics acting on G-Protein Coupled Receptors
(GPCRs). The extension will include targets from different...
Lipoxen has announced that its move to list the company on the
Alternative Investments Market (AIM) has raised £3.78 million (€5.5
million) in a fundraising effort that will allow them to proceed
with preclinical trials to treat disorders...
Vertex Pharmaceuticals and Cystic Fibrosis Foundation Therapeutics
have extended their research collaboration initiated in May 2000,
in which CFFT will provide an additional $22 million to further
develop Vertex's therapies that...
Genevac announces the launch of a new second-generation version of
its EZ-2 centrifugal evaporator, which is able to take tubes,
flasks and vials directly from the synthesis process, providing
flexibility for those switching their...
Researchers are looking into the possibility of using a protein
that undesirably shields a skin poxvirus from the immune system as
the key ingredient in a new topical treatment for inflammatory
diseases.
ADME/toxicity service providers, Cyprotex, launch a new service to
help drug discovery groups assess new oral drug candidates. The
service will equip researchers with new pharmacokinetic insights as
early as possible, aiming to improve...
